ADIAL PHARMACEUTICALS CEO Cary Claiborne's 2023 pay falls 21% to $802K
ADIAL PHARMACEUTICALS reports 2023 executive compensation
By ExecPay News
Published: 3 hours ago
ADIAL PHARMACEUTICALS reported fiscal year 2023 executive compensation information on September 27, 2024.
In 2023, three executives at ADIAL PHARMACEUTICALS received on average a compensation package of $542K, a 15% decrease compared to previous year.
Average pay of disclosed executives at ADIAL PHARMACEUTICALS
Cary J. Claiborne, Chief Executive Officer, received $802K in total, which decreased by 21% compared to 2022. 58% of Claiborne's compensation, or $466K, was in salary. Claiborne also received $190K in bonus, $73K in option awards, as well as $73K in other compensation.
Bankole Johnson, Chief Medical Officer, received a compensation package of $435K, which decreased by 11% compared to previous year. 100% of the compensation package, or $435K, was in salary.
Joseph A. M. Truluck, Chief Financial Officer, earned $389K in 2023, a 12% decrease compared to previous year.
Related executives
You may also like
Source: SEC filing on September 27, 2024.